Synerlab (France)

In September 2025, 50 laboratory-confirmed cases of Legionnaires’ disease (LD) were identified in Albertville, in south-eastern France. Initially, 23 patients were only clinically diagnosed and only confirmed later due to limited sensitivity of the urinary antigen screening test used. All cases occurred within 12 days, suggesting a common point source of massive contamination. Despite investigations and the rapid response of LD surveillance partners, the outbreak source has not yet been identified. Vigilance is maintained to detect possible new cases.

Background: Serum allergen-specific immunoglobulins E (IgE) play a key role in allergy diagnosis along with clinical history and physical examination. Nowadays, allergen multiplex assays allow complex polyallergic cases to be solved as they assess up to 300 allergen-specific IgE. Recently, machine learning has emerged as a trending tool in medicine. The aim was to build a nationwide, open-access database to create an algorithm that could predict allergy diagnosis, severity, category (airborne, food, venom) and culprit allergens. Methods: A retrospective national database was created by the French Society of Allergology in collaboration with AllergoBioNet and the Health Data Hub. Collected data were de-identified patient profiles with five demographic items, twenty clinical items and sIgE results of one allergen multiplex assay. An international crowdsourced machine learning competition was hosted by the Trustii.io platform. Criteria for algorithm evaluation were the F-score (a measure of a model’s accuracy on a dataset) and external validation on patient profiles outside the database (80%-20%, respectively). Results: Data were collected from 4271 patient files. Two hundred and ninety-two data scientists competed with 3135 algorithms. The best F-scores were comprised between 78% and 80%. Models associated with the highest F-scores used gradient boosting classifiers such as LightGBM, CatBoost, XGBoost adapted for tabular datasets with categorical features. Conclusions: We report here the first artificial intelligence models applied to allergen multiplex arrays interpretation in a nationwide real-world database built to be open access. With F-scores close to 80%, the French Allergen Chip Challenge paves the way for a diagnostic prediction tool for practicing allergists.

Wild animal species living in anthropogenic areas are commonly carriers of antimicrobial‐resistant bacteria (AMRB), but their role in the epidemiology of these bacteria is unclear. Several studies on AMRB in wildlife have been cross‐sectional in design and sampled individual animals at only one point in time. To further understand the role of wildlife in maintaining and potentially transmitting these bacteria to humans and livestock, longitudinal studies are needed in which samples are collected from individual animals over multiple time periods. In Europe, free‐ranging yellow‐legged gulls (Larus michahellis) commonly live in industrialized areas, forage in landfills, and have been found to carry AMRB in their feces. Using bacterial metagenomics and antimicrobial resistance characterization, we investigated the spatial and temporal patterns of AMRB in a nesting colony of yellow‐legged gulls from an industrialized area in southern France. We collected 54 cloacal swabs from 31 yellow‐legged gull chicks in 20 nests on three dates in 2016. We found that AMRB in chicks increased over time and was not spatially structured within the gull colony. This study highlights the complex occurrence of AMRB in a free‐ranging wildlife species and contributes to our understanding of the public health risks and implications associated with ARMB‐carrying gulls living in anthropogenic areas.

BackgroundThe French Riviera has been declared free of Lyme Borreliosis (LB) for years. Many patients are referred for presumed LB, sometimes with atypical clinical signs and/or doubtful serology, calling the diagnosis into question.MethodsPatients were assessed for LB diagnosis, depending on clinical presentation, laboratory findings, and further examination by other medical professionals.ResultsAmong 255 patients, 45 (18%) were classified as confirmed LB cases [including 28 ongoing LB (10%) and 17 past LB (8%)], and for 210 (82%) a Lyme borreliosis diagnosis was ruled out. Among ongoing LB, 56% had been exposed to or bitten by ticks, exclusively in rural locations of the Alpes-Maritimes. As a result of the diagnostic procedure, 132 (52%) patients had been treated. An alternative diagnosis was established for 134 (52%) patients, covering a wide range of conditions, including mainly psychological (28%) and neurological conditions (25%) or inflammatory and systemic diseases (22%).ConclusionsOur results strongly suggest the endemicity of LB in the Alpes-Maritimes region. Confirmed LB accounted for 18% of patients while 52% were diagnosed with other conditions.

The recommendations that we formulate in this document come from LABAC, SFBC and FAEEQ. They describe the different steps from the initial application of quality controls, based on risk analysis: the changes of reagent batches or internal quality controls (IQC) batches, the course when IQC are not in accordance with references, the choice of external quality evaluation and the interpretation of its results, the comparability of results obtained in several analysers used in the same laboratory. Lastly, measurement uncertainty, robustness of methods and specificities of near-patient biology and rapid tests are described. Note that these recommendations cannot develop all cases that we could find in laboratories. It remains necessary to carry out an objective strategy, supported with documentary evidences.

Abstract A new, optically active, atropisomeric diphosphane ligand, (2,3,2′,3′‐tetrahydro‐5,5′‐bi(1,4‐benzodioxin)‐6,6′‐diyl)bis‐(diphenylphosphane) (SYNPHOS®), has been synthesized, characterized, and used in ruthenium‐catalyzed asymmetric hydrogenations. This new ligand has been compared with other atropisomeric diphosphanes (BINAP and MeO‐BIPHEP) with respect to their dihedral angles calculated by molecular modeling and the enantioselectivity of their ruthenium‐mediated hydrogenation reactions. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)